Bcf Psych More Meds

Front 1

Buprenorphine

Back 1

(partial opioid agonist) – opiate detoxification.
(subtex)
Or formulation containing buprenorphine and naloxone (suboxone) available for outpatient.
Greater safety of margin than methadone regarding safety margin

Front 2

Tacrine

Back 2

(Cognex)
Anticholinergic used for alzheimers
First line in treatment of neuroleptic induced parkinsonism and for acute dystonia
CNS muscarinic antagonists
s/e: blurry vision (cycloplegia), constipation, urinary retention, sedation and delirium

Front 3

Galantamine

Back 3

(reminyl)
Anticholinergic used for alzheimers
First line in treatment of neuroleptic induced parkinsonism and for acute dystonia
CNS muscarinic antagonists
s/e: blurry vision (cycloplegia), constipation, urinary retention, sedation and delirium

Front 4

Rivastigmine

Back 4

(exelon)
Anticholinergic used for alzheimers
First line in treatment of neuroleptic induced parkinsonism and for acute dystonia
CNS muscarinic antagonists
s/e: blurry vision (cycloplegia), constipation, urinary retention, sedation and delirium

Front 5

Donepezil

Back 5

(aricept)
Anticholinergic used for alzheimers
First line in treatment of neuroleptic induced parkinsonism and for acute dystonia
CNS muscarinic antagonists
s/e: blurry vision (cycloplegia), constipation, urinary retention, sedation and delirium

Front 6

Selegiline

Back 6

MAOI type B
Increases extracellular DA in the striatum
For parkinson dz/ parkinsonism/ dystonia
S/e: hypertensive crisis, arrhythmias, orthostatic HoTN, compulsive behaviors, hallucinations, EPS, dyskinesia
Avoid abrupt cessation

Front 7

Duloxetine

Back 7

CYMBALTA
Heterocyclic antidepressant – SNRIs
Inhibits NE and serotonin reuptake
MDD, GAD, DM neuropathy
s/e hepatotoxicity, seizures, SIAH, hyponatremia

Front 8

Oxcarbazepine

Back 8

Anticonvulsants
And for bipolar d/o
Blocks voltage-sensitive Na channels and stabilizes neural membranes, inhibits repetitive firing and decreases synaptic impulse propagation
Check Creatinine at baseline
Stevens-Johnson, thrombocytopenia, leukopenia, hyponatremia

Front 9

topiramate

Back 9

(topomax)
Anticonvulsants
Partial seizures, and Migraine HA
s/e: nephrolithiasis, metabolic acidosis, osteomalacia and osteoporosis

Front 10

Benztropine

Back 10

For parkinsonism and extrapyramidal rxns and dystonic rxns
Antagonizes acetylcholine and histamine receptors
s/e: tachycardia, psychosis (anticholinergic), dry mouth, constipation, urinary retention

Front 11

Diphenylhydramine

Back 11

Anxiolytic
Hypnotic/sleep med
Useful for extrapyramidal sx and short term insomnia
Nonselective antihistamine
s/e: hemolytic anemia, agranulocytosis, pancytopenia, constipation, blurred vision

Front 12

Amantadine

Back 12

For influenza, parkinsonism, extrapyramidal disorders
Potentiates CNS dopaminergic responses
Check Cr at baseline

Front 13

Naltrexone

Back 13

Mu opioid antagonist that is used to prevent alcohol relapse and to lessen the severity of relapse in pts with alcohol dependence.
Initiated once pt has been DETOXIFIED.
At least 1 wk after last opioid exposure otherwise can result in withdrawal.
Reduces alcohol craving.
Best when combined with psychosocial interventions.

Front 14

Clonidine

Back 14

CNS alpha 2 adrenoreceptor agonist. Presynaptic autoreceptor that inhibits release of CNS NE.
Primarily used as anti-HTN.
Decreases autonomic symptoms.
Treatment of ADHD and tourette’s syndrome may be useful for impulsiveness and other forms of behavioral dyscontrol.
s/e include sedation, dizziness and HoTN.

Front 15

Methylphenidate

Back 15

Ritalin
psychostimulant
ADHD, narcolepsy, and some forms of depression
Alteration of CNS monoamine function
Facilitating endogenous NT release
Labilities inducing tolerance and psychological dependence leading to abuse.
S/e sympathomimetic: tachy, insomnia, anxiety, HTN and diaphoresis.

Front 16

Dexmethylphenidate

Back 16

Dexedrine
A psychostimulant
ADHD, narcolepsy, and some forms of depression
Alteration of CNS monoamine function
Facilitating endogenous NT release
Labilities inducing tolerance and psychological dependence leading to abuse.
S/e sympathomimetic: tachy, insomnia, anxiety, HTN and diaphoresis.

Front 17

D and L amphetamine

Back 17

Adderall
psychostimulant
ADHD, narcolepsy, and some forms of depression
Alteration of CNS monoamine function
Facilitating endogenous NT release
Labilities inducing tolerance and psychological dependence leading to abuse.
S/e sympathomimetic: tachy, insomnia, anxiety, HTN and diaphoresis.

Front 18

Atomoxetine

Back 18

(Strattera)
ADHD
Selective NE reuptake inhibitor.

Front 19

Propranolol

Back 19

Anxiolytic
Beta blocker
Alter behavior and mood states by altering both CNS and peripheral catecholamine function.
Diminish central arousal
Peripherally reduce tachycardia, tremor, sweating and hyperventilation.
s/e: bradycardia, HoTN, asthma exacerbation and masking hypoglycemia.

Front 20

Eszopiclone

Back 20

LUNESTA
Hypnotic/sleep med
Interacts w/ GABA receptor complexes
s/e: withdrawal if abrupt, amnesia, hallucinations, aggressive behavior, dry mouth,

Front 21

Ramelteon

Back 21

ROZEREM
Hypnotic/sleep med
Binds to melatonin MT1 and MT2 receptors (agonist)
s/e: HA, nausea, diarrhea, dizziness, fatigue

Front 22

Memantine

Back 22

(namenda)
Antagonist at the excitatory glutamatergic NMDA receptor. Approved for moderate-to-severe dementia of Alzheimer type. Antagonism of the NMDA receptor may help prevent glutamate-mediated excitotoxicity and improve function of neurons in some forms of memory.